AbbVie to Present Data From Its Migraine Portfolio at the 2021 International Headache Congress

NORTH CHICAGO, Ill., Sept. 8, 2021 /PRNewswire/ — AbbVie (NYSE: ABBV) today announced that data from its migraine portfolio will be presented at the International Headache Congress 2021, held jointly this year by the International Headache Society and the European Headache Federation, from September 8-12. The company will share a total of 23 abstracts, including two oral presentations and one abstract lecture.  


Get every new post delivered right to your inbox.

Original Source